W. Shaw Robert Buys 2,500 Shares of Ultralife Co. (NASDAQ:ULBI) Stock

Ultralife Co. (NASDAQ:ULBI) Director W. Shaw Robert bought 2,500 shares of the stock in a transaction on Tuesday, November 12th. The stock was purchased at an average price of $7.91 per share, for a total transaction of $19,775.00. Following the completion of the purchase, the director now directly owns 65,250 shares in the company, valued at approximately $516,127.50. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Ultralife Trading Down 3.1 %

NASDAQ ULBI opened at $7.75 on Thursday. The company has a quick ratio of 2.06, a current ratio of 4.07 and a debt-to-equity ratio of 0.07. The stock’s 50-day simple moving average is $9.05 and its two-hundred day simple moving average is $10.30. Ultralife Co. has a twelve month low of $6.36 and a twelve month high of $13.39. The company has a market capitalization of $128.81 million, a price-to-earnings ratio of 14.09 and a beta of 0.98.

Institutional Trading of Ultralife

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Quadrature Capital Ltd bought a new stake in shares of Ultralife in the 1st quarter worth approximately $200,000. Empowered Funds LLC lifted its stake in Ultralife by 7.8% in the first quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock worth $277,000 after purchasing an additional 2,275 shares during the last quarter. O Shaughnessy Asset Management LLC purchased a new stake in Ultralife during the first quarter valued at about $100,000. Hillsdale Investment Management Inc. bought a new position in shares of Ultralife during the first quarter valued at about $166,000. Finally, Vanguard Group Inc. increased its holdings in shares of Ultralife by 1.3% in the first quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock worth $4,545,000 after buying an additional 6,640 shares during the period. Hedge funds and other institutional investors own 30.68% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com cut Ultralife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, October 3rd.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.